Biogen (BIIB) had the highest return between September 1, 2022 and October 15, 2022 by a large-cap US stock, returning 35.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Biogen (BIIB) | 9/1/2022 - 10/15/2022 | 35.87% |
Regeneron Pharmaceuticals (REGN) | 9/1/2022 - 10/15/2022 | 27.43% |
Roivant Sciences (ROIV) | 9/1/2022 - 10/15/2022 | 26.52% |
Nutanix (NTNX) | 9/1/2022 - 10/15/2022 | 25.54% |
QXO (QXO) | 9/1/2022 - 10/15/2022 | 22.95% |
YPF Sociedad Anonima (YPF) | 9/1/2022 - 10/15/2022 | 21.76% |
Ascendis Pharma A-S (ASND) | 9/1/2022 - 10/15/2022 | 19.8% |
DexCom (DXCM) | 9/1/2022 - 10/15/2022 | 19.24% |
TechnipFMC (FTI) | 9/1/2022 - 10/15/2022 | 16.42% |
Globe Life (GL) | 9/1/2022 - 10/15/2022 | 12.88% |
Schlumberger (SLB) | 9/1/2022 - 10/15/2022 | 12.81% |
Interactive Brokers (IBKR) | 9/1/2022 - 10/15/2022 | 12.29% |
Texas Pacific Land Trust (TPL) | 9/1/2022 - 10/15/2022 | 12.27% |
PG&E (PCG) | 9/1/2022 - 10/15/2022 | 12.26% |
AerCap (AER) | 9/1/2022 - 10/15/2022 | 12.05% |
TKO (TKO) | 9/1/2022 - 10/15/2022 | 12% |
Royal Caribbean Cruises (RCL) | 9/1/2022 - 10/15/2022 | 11.25% |
Unum (UNM) | 9/1/2022 - 10/15/2022 | 11.21% |
ConocoPhillips (COP) | 9/1/2022 - 10/15/2022 | 10.92% |
Eli Lilly and (LLY) | 9/1/2022 - 10/15/2022 | 10.1% |
Allstate (ALL) | 9/1/2022 - 10/15/2022 | 9.72% |
Ionis Pharmaceuticals (IONS) | 9/1/2022 - 10/15/2022 | 9.31% |
Permian Resources (PR) | 9/1/2022 - 10/15/2022 | 8.91% |
LPL Financial (LPLA) | 9/1/2022 - 10/15/2022 | 8.87% |
Erie Indemnity (ERIE) | 9/1/2022 - 10/15/2022 | 8.85% |
Large-cap stocks are treated as having a market cap of $10B+.
